RxDoctor Payments Data

Ashley Marr

Adult Health · Jackson, MINPI 1396375366

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.5% of the total across 211 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Novartis at 28.4% of the total. Reporting peaked in 2022 at $1,395 and has fallen 69.3% since, to $428 in 2025. Among adult health clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,783in general payments, 2019–2025

Across 211 payments — averaging $17.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Johnson & Johnson$815
  • E.r. Squibb & Sons, L.L.C.$431
  • Boston Scientific$285
  • Abiomed$159
  • AstraZeneca$142
  • plus $878 from 17 others

What the payments were for

  • Food & beverage$3,65197%
  • Education$1323%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,783 in reported general payments places this provider in the 90th percentile of 527 adult health providers in Michigan.

See all adult health providers in Michigan

Medicare billing

Part B allowed, 2024
$5,900
Medicare patients
63
Services billed
89

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor20$9,987
Metoprolol Succinate25$475
Rosuvastatin Calcium16$370
Atorvastatin Calcium27$332
Lisinopril16$306
ClopidogrelClopidogrel Bisulfate18$257
Doxazosin Mesylate14$243
Losartan Potassium14$231
Metoprolol Tartrate39$220
Carvedilol15$101
Spironolactone12$97
Amlodipine Besylate18$90

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBrilinta$142$9,98720 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 527 adult health providers in Michigan.

Other adult health in Jackson

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →